Injectable HIV therapy may tame inflammation better than pills, new study hopes to prove
NCT ID NCT05303337
First seen Oct 31, 2025 · Last updated May 23, 2026 · Updated 29 times
Summary
This study looks at 120 people with HIV who switch from daily oral pills to a long-acting injectable treatment. Researchers want to see if the injectable reduces inflammation and improves gut health better than pills. The goal is to understand how different treatments affect the hidden HIV reservoir in the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Européen Marseille
RECRUITINGMarseille, 13003, France
Contact
Contact
Conditions
Explore the condition pages connected to this study.